Kiora Pharmaceuticals, Inc. (KPRX)
2.05
+0.03
(+1.49%)
USD |
NASDAQ |
Mar 04, 15:49
Kiora Pharmaceuticals Free Cash Flow : -10.02M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Celldex Therapeutics, Inc. | -213.66M |
| Plus Therapeutics, Inc. | -15.78M |
| Atossa Therapeutics, Inc. | -26.29M |
| Abeona Therapeutics, Inc. | -82.36M |
| Cell Source, Inc. | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.273M |
| Cash from Investing (Quarterly) | 5.741M |
| Free Cash Flow Per Share (Quarterly) | -0.292 |
| Free Cash Flow to Equity (Quarterly) | -1.247M |
| Free Cash Flow to Firm (Quarterly) | -1.274M |
| Free Cash Flow Yield | -125.6% |